SCHEMBL17899573

SCHEMBL17899573

COc1cccc(/C=C2\CCC/C(=C\c3cccc(OC)c3OC)C2=O)c1OC

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.76
CRHR2 Q13324 1/20 0.76
KMT2A Q03164 2/20 0.66
ALDH1A1 P00352 2/20 0.66
MAPT P10636 2/20 0.66
POLB P06746 1/20 0.66
RAB9A P51151 2/20 0.62
NPC1 O15118 1/20 0.62
MAOB P27338 1/20 0.60
EGFR P00533 1/20 0.60
MEN1 O00255 1/20 0.59
NOD2 Q9HC29 1/20 0.59
HSD17B3 P37058 1/20 0.57
NFE2L2 Q16236 2/20 0.57
PLA2G1B P04054 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ATG4B Q9Y4P1 1/20 0.53
PDE4B Q07343 1/20 0.51
HSD11B1 P28845 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25842296 0.93 CRHBP (0.67) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL1524404 0.90 CRHBP (0.61) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL1524403 0.90 CRHBP (0.61) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL3438404 0.87 RAB9A (0.61) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL3438405 0.87 RAB9A (0.61) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL17899531 0.87 MAOB (0.70) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL19050163 0.86 CRHBP (1.00) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL16745481 0.86 EGFR (0.77) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL22474539 0.85 CRHBP (0.62) CRHBPCRHR2KMT2AALDH1A1MAPT
SCHEMBL1524343 0.84 ALDH1A1 (0.61) CRHBPCRHR2KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2023-11-09 US disclosed
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2023-07-25 US disclosed
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer BAYLOR COLLEGE OF MEDICINE (US) 2022-04-26 US disclosed
US-20210115017-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2021-04-22 US disclosed
US-10875841-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2020-12-29 US disclosed
US-20200071300-A1 Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents BAYLOR COLLEGE OF MEDICINE (US) 2020-03-05 US disclosed
WO-2016109470-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR PROTEINS AND THEIR USE IN THE TREATMENT OF CANCER BAYLOR COLLEGE OF MEDICINE (US) 2016-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071300-A1 Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents NCOA3, FABP3, NCOA1 CRHBP 137/4885CRHR2 256/4885KMT2A 4286/4885
US-11312676-B2 Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer NCOA2, NCOA1, NCOA3 CRHBP 145/4885CRHR2 707/4885KMT2A 3709/4885
US-20210115017-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS NCOA3, FABP3, NCOA1 CRHBP 137/4885CRHR2 256/4885KMT2A 4286/4885
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents NCOA3, FABP3, NCOA1 CRHBP 137/4885CRHR2 256/4885KMT2A 4286/4885
US-10875841-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents NCOA3, FABP3, NCOA1 CRHBP 137/4885CRHR2 256/4885KMT2A 4286/4885
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS NCOA3, FABP3, NCOA1 CRHBP 137/4885CRHR2 256/4885KMT2A 4286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.